CAS 167354-41-8: Zosuquidar
Description:Zosuquidar, with the CAS number 167354-41-8, is a small molecule that functions primarily as a P-glycoprotein inhibitor. It is notable for its role in enhancing the efficacy of chemotherapeutic agents by preventing the efflux of these drugs from cancer cells, thereby increasing their intracellular concentrations. Zosuquidar is characterized by its ability to cross the blood-brain barrier, which is significant for treating central nervous system malignancies. The compound has a relatively low solubility in water, which can affect its bioavailability and pharmacokinetics. Its chemical structure includes multiple aromatic rings and nitrogen-containing groups, contributing to its pharmacological properties. Zosuquidar has been investigated in various clinical settings, particularly in combination therapies for cancers resistant to standard treatments. Overall, its mechanism of action and pharmacological profile make it a valuable candidate in cancer therapeutics, particularly in overcoming multidrug resistance.
Formula:C32H31F2N3O2
InChI:InChI=1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m1/s1
InChI key:InChIKey=IHOVFYSQUDPMCN-DBEBIPAYSA-N
SMILES:FC1(F)C2C=3C=CC=CC3C(C=4C=CC=CC4C21)N5CCN(CC5)CC(O)COC6=CC=CC7=NC=CC=C76
- Synonyms:
- (2R)-1-{4-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride
- (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
- (αR)-4-[(1Aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol
- 1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-, (αR)-
- Lsn 335979
- Zosuquidar
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol REF: IN-DA00ABM5CAS: 167354-41-8 | 98% | 115.00 €~504.00 € | Tue 06 May 25 |
![]() | Zosuquidar REF: TM-T6018LCAS: 167354-41-8 | - - - | 1,234.00 €~2,332.00 € | Tue 13 May 25 |
![]() | Zosuquidar REF: 3D-FZ104159CAS: 167354-41-8 | Min. 95% | - - - | Discontinued product |

(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
Ref: IN-DA00ABM5
1mg | 115.00 € | ||
5mg | 504.00 € |

Zosuquidar
Ref: TM-T6018L
25mg | 1,234.00 € | ||
50mg | 1,823.00 € | ||
100mg | 2,332.00 € |

Zosuquidar
Ref: 3D-FZ104159
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |